Journal of Yeungnam Medical Science

영남대 의대 학술지 편집위원회 (Yeungnam University College of Medicine, Yeungnam University Institute Medical Science)
권호 표지
DOI QR코드

DOI QR Code

F-18 fluorodeoxyglucose positron emission tomography/computed tomography in the infection of heart

  • Kong, Eunjung (Department of Nuclear Medicine, Yeungnam University College of Medicine)
  • 투고 : 2020.06.07
  • 심사 : 2020.08.10
  • 발행 : 2021.04.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Infections involving the heart are becoming increasingly common, and a timely diagnosis of utmost importance, despite its challenges. F-18 fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) is a recently introduced diagnostic tool in cardiology. This review focuses on the current evidence for the use of FDG PET/CT in the diagnosis of infective endocarditis, cardiac implantable device infection, left ventricular assist device infection, and secondary complications. The author discusses considerations when using FDG PET/CT in routine clinical practice, patient preparation for reducing physiologic myocardial uptake, acquisition of images, and interpretation of PET/CT findings. This review also functions to highlight the need for a standardized acquisition protocol.

키워드

참고문헌

  1. Sunil M, Hieu HQ, Arjan Singh RS, Ponnampalavanar S, Siew KS, Loch A. Evolving trends in infective endocarditis in a developing country: a consequence of medical progress? Ann Clin Microbiol Antimicrob 2019;18:43. https://doi.org/10.1186/s12941-019-0341-x
  2. Murillo H, Restrepo CS, Marmol-Velez JA, Vargas D, Ocazionez D, Martinez-Jimenez S, et al. Infectious diseases of the heart: pathophysiology, clinical and imaging overview. Radiographics 2016;36:963-83. https://doi.org/10.1148/rg.2016150225
  3. Johansen JB, Jorgensen OD, Moller M, Arnsbo P, Mortensen PT, Nielsen JC. Infection after pacemaker implantation: infection rates and risk factors associated with infection in a population-based cohort study of 46299 consecutive patients. Eur Heart J 2011;32:991-8. https://doi.org/10.1093/eurheartj/ehq497
  4. Li JS, Sexton DJ, Mick N, Nettles R, Fowler VG Jr, Ryan T, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 2000;30:633-8. https://doi.org/10.1086/313753
  5. Habib G, Lancellotti P, Antunes MJ, Bongiorni MG, Casalta JP, Del Zotti F, et al. 2015 ESC guidelines for the management of infective endocarditis: the Task Force for the Management of Infective Endocarditis of the European Society ofCardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J 2015;36:3075-128. https://doi.org/10.1093/eurheartj/ehv319
  6. Pizzi MN, Roque A, Fernandez-Hidalgo N, Cuellar-Calabria H, Ferreira-Gonzalez I, Gonzalez-Alujas MT, et al. Improving the diagnosis of infective endocarditis in prosthetic valves and intracardiac devices with 18F-fluordeoxyglucose positron emission tomography/computed tomography angiography: initial results at an infective endocarditis referral center. Circulation 2015; 132:1113-26. https://doi.org/10.1161/CIRCULATIONAHA.115.015316
  7. Saby L, Laas O, Habib G, Cammilleri S, Mancini J, Tessonnier L, et al. Positron emission tomography/computed tomography for diagnosis of prosthetic valve endocarditis: increased valvular 18F-fluorodeoxyglucose uptake as a novel major criterion. J Am Coll Cardiol 2013;61:2374-82. https://doi.org/10.1016/j.jacc.2013.01.092
  8. Dilsizian V, Achenbach S, Narula J. Adding or selecting imaging modalities for incremental diagnosis: a case study of 18FDG PET/CT in prosthetic valve endocarditis. JACC Cardiovasc Imaging 2013;6:1020-1. https://doi.org/10.1016/j.jcmg.2013.07.005
  9. Dilsizian V, Bacharach SL, Beanlands RS, Bergmann SR, Delbeke D, Dorbala S, et al. ASNC imaging guidelines/SNMMI procedure standard for positron emission tomography (PET) nuclear cardiology procedures. J Nucl Cardiol 2016;23:1187-226. https://doi.org/10.1007/s12350-016-0522-3
  10. Chen W, Sajadi MM, Dilsizian V. Merits of FDG PET/CT and functional molecular imaging over anatomic imaging with echocardiography and CT angiography for the diagnosis of cardiac device infections. JACC Cardiovasc Imaging 2018;11:1679-91. https://doi.org/10.1016/j.jcmg.2018.08.026
  11. Doherty JU, Kort S, Mehran R, Schoenhagen P, Soman P. ACC/AATS/AHA/ASE/ASNC/HRS/SCAI/SCCT/SCMR/STS 2017 appropriate use criteria for multimodality imaging in valvular heart disease: a report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and Society of Thoracic Surgeons. J Am Coll Cardiol 2017;70:1647-72. https://doi.org/10.1016/j.jacc.2017.07.732
  12. Baddour LM, Wilson WR, Bayer AS, Fowler VG Jr, Tleyjeh IM, Rybak MJ, et al. Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications: a scientific statement for healthcare professionals from the American Heart Association. Circulation 2015;132:1435-86. https://doi.org/10.1161/CIR.0000000000000296
  13. Mahmood M, Kendi AT, Ajmal S, Farid S, O'Horo JC, Chareonthaitawee P, et al. Meta-analysis of 18F-FDG PET/CT in the diagnosis of infective endocarditis. J Nucl Cardiol 2019;26:922-35. https://doi.org/10.1007/s12350-017-1092-8
  14. Swart LE, Gomes A, Scholtens AM, Sinha B, Tanis W, Lam MG, et al. Improving the diagnostic performance of 18F-fluorodeoxyglucose positron-emission tomography/computed tomography in prosthetic heart valve endocarditis. Circulation 2018;138:1412-27. https://doi.org/10.1161/CIRCULATIONAHA.118.035032
  15. de Camargo RA, Sommer Bitencourt M, Meneghetti JC, Soares J, Goncalves LF, Buchpiguel CA, et al. The role of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in the diagnosis of left-sided endocarditis: native vs prosthetic valves endocarditis. Clin Infect Dis 2020;70:583-94.
  16. San S, Ravis E, Tessonier L, Philip M, Cammilleri S, Lavagna F, et al. Prognostic value of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in infective endocarditis. J Am Coll Cardiol 2019;74:1031-40. https://doi.org/10.1016/j.jacc.2019.06.050
  17. Kouijzer IJ, Berrevoets MA, Aarntzen EH, de Vries J, van Dijk AP, Oyen WJ, et al. 18F-fluorodeoxyglucose positron-emission tomography combined with computed tomography as a diagnostic tool in native valve endocarditis. Nucl Med Commun 2018;39:747-52. https://doi.org/10.1097/MNM.0000000000000864
  18. Kestler M, Munoz P, Rodriguez-Creixems M, Rotger A, Jimenez-Requena F, Mari A, et al. Role of (18)F-FDG PET in patients with infectious endocarditis. J Nucl Med 2014;55:1093-8. https://doi.org/10.2967/jnumed.113.134981
  19. Kusumoto FM, Schoenfeld MH, Wilkoff BL, Berul CI, Birgersdotter-Green UM, Carrillo R, et al. 2017 HRS expert consensus statement on cardiovascular implantable electronic device lead management and extraction. Heart Rhythm 2017;14:e503-51. https://doi.org/10.1016/j.hrthm.2017.09.001
  20. Athan E, Chu VH, Tattevin P, Selton-Suty C, Jones P, Naber C, et al. Clinical characteristics and outcome of infective endocarditis involving implantable cardiac devices. JAMA 2012;307:1727-35. https://doi.org/10.1001/jama.2012.497
  21. Podoleanu C, Deharo JC. Management of cardiac implantable electronic device infection. Arrhythm Electrophysiol Rev 2014;3:184-9. https://doi.org/10.15420/aer.2014.3.3.184
  22. Sarrazin JF, Philippon F, Tessier M, Guimond J, Molin F, Champagne J, et al. Usefulness of fluorine-18 positron emission tomography/computed tomography for identification of cardiovascular implantable electronic device infections. J Am Coll Cardiol 2012;59:1616-25. https://doi.org/10.1016/j.jacc.2011.11.059
  23. Juneau D, Golfam M, Hazra S, Zuckier LS, Garas S, Redpath C, et al. Positron emission tomography and single-photon emission computed tomography imaging in the diagnosis of cardiac implantable electronic device infection: a systematic review and meta-analysis. Circ Cardiovasc Imaging 2017;10:e005772. https://doi.org/10.1161/CIRCIMAGING.116.005772
  24. Mahmood M, Kendi AT, Farid S, Ajmal S, Johnson GB, Baddour LM, et al. Role of 18F-FDG PET/CT in the diagnosis of cardiovascular implantable electronic device infections: a meta-analysis. J Nucl Cardiol 2019;26:958-70. https://doi.org/10.1007/s12350-017-1063-0
  25. Jimenez-Ballve A, Perez-Castejon MJ, Delgado-Bolton RC, Sanchez-Enrique C, Vilacosta I, Vivas D, et al. Assessment of the diagnostic accuracy of 18F-FDG PET/CT in prosthetic infective endocarditis and cardiac implantable electronic device infection: comparison of different interpretation criteria. Eur J Nucl Med Mol Imaging 2016;43:2401-12. https://doi.org/10.1007/s00259-016-3463-9
  26. Diemberger I, Bonfiglioli R, Martignani C, Graziosi M, Biffi M, Lorenzetti S, et al. Contribution of PET imaging to mortality risk stratification in candidates to lead extraction for pacemaker or defibrillator infection: a prospective single center study. Eur J Nucl Med Mol Imaging 2019;46:194-205. https://doi.org/10.1007/s00259-018-4142-9
  27. Kadakia S, Moore R, Ambur V, Toyoda Y. Current status of the implantable LVAD. Gen Thorac Cardiovasc Surg 2016;64:501-8. https://doi.org/10.1007/s11748-016-0671-y
  28. Koval CE, Thuita L, Moazami N, Blackstone E. Evolution and impact of drive-line infection in a large cohort of continuous-flow ventricular assist device recipients. J Heart Lung Transplant 2014;33:1164-72. https://doi.org/10.1016/j.healun.2014.05.011
  29. Bernhardt AM, Pamirsad MA, Brand C, Reichart D, Tienken M, Barten MJ, et al. The value of fluorine-18 deoxyglucose positron emission tomography scans in patients with ventricular assist device specific infections. Eur J Cardiothorac Surg 2017;51:1072-7. https://doi.org/10.1093/ejcts/ezx016
  30. Tam MC, Patel VN, Weinberg RL, Hulten EA, Aaronson KD, Pagani FD, et al. Diagnostic accuracy of FDG PET/CT in suspected LVAD infections: a case series, systematic review, and meta-analysis. JACC Cardiovasc Imaging 2020;13:1191-202. https://doi.org/10.1016/j.jcmg.2019.04.024
  31. Akin S, Muslem R, Constantinescu AA, Manintveld OC, Birim O, Brugts JJ, et al. 18F-FDG PET/CT in the diagnosis and management of continuous flow left ventricular assist device infections: a case series and review of the literature. ASAIO J 2018;64:e11-9. https://doi.org/10.1097/MAT.0000000000000552
  32. Kim J, Feller ED, Chen W, Liang Y, Dilsizian V. FDG PET/CT for early detection and localization of left ventricular assist device infection: impact on patient management and outcome. JACC Cardiovasc Imaging 2019;12:722-9. https://doi.org/10.1016/j.jcmg.2018.01.024
  33. de Vaugelade C, Mesguich C, Nubret K, Camou F, Greib C, Dournes G, et al. Infections in patients using ventricular-assist devices: comparison of the diagnostic performance of 18F-FDG PET/CT scan and leucocyte-labeled scintigraphy. J Nucl Cardiol 2019;26:42-55. https://doi.org/10.1007/s12350-018-1323-7
  34. Sommerlath Sohns JM, Krohn H, Schode A, Derlin T, Haverich A, Schmitto JD, et al. 18F-FDG PET/CT in left-ventricular assist device infection: initial results supporting the usefulness of image-guided therapy. J Nucl Med 2020;61:971-6. https://doi.org/10.2967/jnumed.119.237628
  35. Kanapinn P, Burchert W, Korperich H, Korfer J. 18F-FDG PET/CT-imaging of left ventricular assist device infection: a retrospective quantitative intrapatient analysis. J Nucl Cardiol 2019;26:1212-21. https://doi.org/10.1007/s12350-017-1161-z
  36. Dell'Aquila AM, Avramovic N, Mastrobuoni S, Motekallemi A, Wisniewski K, Scherer M, et al. Fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography for improving diagnosis of infection in patients on CF-LVAD: longing for more 'insights'. Eur Heart J Cardiovasc Imaging 2018;19:532-43. https://doi.org/10.1093/ehjci/jex158
  37. Avramovic N, Dell'Aquila AM, Weckesser M, Milankovic D, Vrachimis A, Sindermann JR, et al. Metabolic volume performs better than SUVmax in the detection of left ventricular assist device driveline infection. Eur J Nucl Med Mol Imaging 2017;44:1870-7. https://doi.org/10.1007/s00259-017-3732-2
  38. Van Riet J, Hill EE, Gheysens O, Dymarkowski S, Herregods MC, Herijgers P, et al. (18)F-FDG PET/CT for early detection of embolism and metastatic infection in patients with infective endocarditis. Eur J Nucl Med Mol Imaging 2010;37:1189-97. https://doi.org/10.1007/s00259-010-1380-x
  39. Mikail N, Benali K, Mahida B, Vigne J, Hyafil F, Rouzet F, et al. 18F-FDG-PET/CT imaging to diagnose septic emboli and mycotic aneurysms in patients with endocarditis and cardiac device infections. Curr Cardiol Rep 2018;20:14. https://doi.org/10.1007/s11886-018-0956-0
  40. Orvin K, Goldberg E, Bernstine H, Groshar D, Sagie A, Kornowski R, et al. The role of FDG-PET/CT imaging in early detection of extra-cardiac complications of infective endocarditis. Clin Microbiol Infect 2015;21:69-76. https://doi.org/10.1016/j.cmi.2014.08.012
  41. Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP 3rd, Guyton RA, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2014;63:2438-88. https://doi.org/10.1016/j.jacc.2014.02.537
  42. Wintenberger C, Guery B, Bonnet E, Castan B, Cohen R, Diamantis S, et al. Proposal for shorter antibiotic therapies. Med Mal Infect 2017;47:92-141. https://doi.org/10.1016/j.medmal.2017.01.007
  43. Puerta-Alcalde P, Cuervo G, Simonetti AF, Gracia-Sanchez L, Ortiz D, Garcia-Vidal C. PET/CT added to Duke criteria facilitates diagnosis and monitoring of long-term suppressive therapy of prosthetic endocarditis. Infect Dis (Lond) 2017;49:698-701. https://doi.org/10.1080/23744235.2017.1300683
  44. Garcia JR, Fortuny C, Riaza L, Soler M, Bassa P, Riera E. Diagnosis by (18)F-FDG PET/CT of infective endocarditis, staging and monitoring of antibiotic treatment after transposition of surgically corrected great arteries. Rev Esp Med Nucl Imagen Mol 2016;35:115-7.
  45. Aguade Bruix S, Roque Perez A, Cuellar Calabria H, Pizzi MN. Cardiac 18F-FDG PET/CT procedure for the diagnosis of prosthetic endocarditis and intracardiac devices. Rev Esp Med Nucl Imagen Mol 2018;37:163-71.
  46. Scholtens AM, Swart LE, Verberne HJ, Tanis W, Lam MG, Budde RP. Confounders in FDG-PET/CT imaging of suspected prosthetic valve endocarditis. JACC Cardiovasc Imaging 2016;9:1462-5. https://doi.org/10.1016/j.jcmg.2016.01.024
  47. Yoshinaga K, Tamaki N. Imaging myocardial metabolism. Curr Opin Biotechnol 2007;18:52-9. https://doi.org/10.1016/j.copbio.2006.11.003
  48. Randle PJ, Garland PB, Hales CN, Newsholme EA. The glucose fatty-acid cycle: its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1963;1:785-9.
  49. Mochizuki T, Tsukamoto E, Kuge Y, Kanegae K, Zhao S, Hikosaka K, et al. FDG uptake and glucose transporter subtype expressions in experimental tumor and inflammation models. J Nucl Med 2001;42:1551-5.
  50. Depre C, Vanoverschelde JL, Taegtmeyer H. Glucose for the heart. Circulation 1999;99:578-88. https://doi.org/10.1161/01.CIR.99.4.578
  51. Osborne MT, Hulten EA, Murthy VL, Skali H, Taqueti VR, Dorbala S, et al. Patient preparation for cardiac fluorine-18 fluorodeoxyglucose positron emission tomography imaging of inflammation. J Nucl Cardiol 2017;24:86-99. https://doi.org/10.1007/s12350-016-0502-7
  52. Dorbala S, Di Carli MF, Delbeke D, Abbara S, DePuey EG, Dilsizian V, et al. SNMMI/ASNC/SCCT guideline for cardiac SPECT/CT and PET/CT 1.0. J Nucl Med 2013;54:1485-507. https://doi.org/10.2967/jnumed.112.105155
  53. Kumita S, Yoshinaga K, Miyagawa M, Momose M, Kiso K, Kasai T, et al. Recommendations for 18F-fluorodeoxyglucose positron emission tomography imaging for diagnosis of cardiac sarcoidosis-2018 update: Japanese Society of NuclearCardiology recommendations. J Nucl Cardiol 2019;26:1414-33. https://doi.org/10.1007/s12350-019-01755-3
  54. Asmal AC, Leary WP, Thandroyen F, Botha J, Wattrus S. A dose-response study of the anticoagulant and lipolytic activities of heparin in normal subjects. Br J Clin Pharmacol 1979;7:531-3. https://doi.org/10.1111/j.1365-2125.1979.tb01000.x
  55. Persson E, Nordenstrom J, Nilsson-Ehle P, Hagenfeldt L, Wahren J. Plasma lipolytic activity and substrate oxidation after intravenous administration of heparin and a low molecular weight heparin fragment. Clin Physiol 1990;10:573-83. https://doi.org/10.1111/j.1475-097X.1990.tb00449.x
  56. Scholtens AM, Verberne HJ, Budde RP, Lam MG. Additional heparin preadministration improves cardiac glucose metabolism suppression over low-carbohydrate diet alone in 18F-FDG PET imaging. J Nucl Med 2016;57:568-73. https://doi.org/10.2967/jnumed.115.166884
  57. Gaeta C, Fernandez Y, Pavia J, Flotats A, Artigas C, Deportos J, et al. Reduced myocardial 18F-FDG uptake after calcium channel blocker administration. Initial observation for a potential new method to improve plaque detection. Eur J Nucl Med Mol Imaging 2011;38:2018-24. https://doi.org/10.1007/s00259-011-1873-2
  58. Demeure F, Hanin FX, Bol A, Vincent MF, Pouleur AC, Gerber B, et al. A randomized trial on the optimization of 18F-FDG myocardial uptake suppression: implications for vulnerable coronary plaque imaging. J Nucl Med 2014;55:1629-35. https://doi.org/10.2967/jnumed.114.138594
  59. Caldarella C, Leccisotti L, Treglia G, Giordano A. Which is the optimal acquisition time for FDG PET/CT imaging in patients with infective endocarditis? J Nucl Cardiol 2013;20:307-9. https://doi.org/10.1007/s12350-012-9667-x
  60. Scholtens AM, Swart LE, Verberne HJ, Budde RP, Lam MG. Dual-time-point FDG PET/CT imaging in prosthetic heart valve endocarditis. J Nucl Cardiol 2018;25:1960-7. https://doi.org/10.1007/s12350-017-0902-3
  61. Asmar A, Ozcan C, Diederichsen AC, Thomassen A, Gill S. Clinical impact of 18F-FDG-PET/CT in the extra cardiac work-up of patients with infective endocarditis. Eur Heart J Cardiovasc Imaging 2014;15:1013-9. https://doi.org/10.1093/ehjci/jeu054
  62. Slomka PJ, Nishina H, Berman DS, Kang X, Akincioglu C, Friedman JD, et al. "Motion-frozen" display and quantification of myocardial perfusion. J Nucl Med 2004;45:1128-34.
  63. Pizzi MN, Dos-Subira L, Roque A, Fernandez-Hidalgo N, Cuellar-Calabria H, Pijuan Domenech A, et al. 18F-FDG-PET/CT angiography in the diagnosis of infective endocarditis and cardiac device infection in adult patients with congenital heart disease and prosthetic material. Int J Cardiol 2017;248:396-402. https://doi.org/10.1016/j.ijcard.2017.08.008
  64. Balmforth D, Chacko J, Uppal R. Does positron emission tomography/computed tomography aid the diagnosis of prosthetic valve infective endocarditis? Interact Cardiovasc Thorac Surg 2016;23:648-52. https://doi.org/10.1093/icvts/ivw177
  65. Mathieu C, Mikail N, Benali K, Iung B, Duval X, Nataf P, et al. Characterization of 18F-fluorodeoxyglucose uptake pattern in noninfected prosthetic heart valves. Circ Cardiovasc Imaging 2017;10:e005585.
  66. Scholtens AM, Budde RP, Lam MG, Verberne HJ. FDG PET/CT in prosthetic heart valve endocarditis: there is no need to wait. J Nucl Cardiol 2017;24:1540-1. https://doi.org/10.1007/s12350-017-0938-4
  67. Abikhzer G, Martineau P, Gregoire J, Finnerty V, Harel F, Pelletier-Galarneau M. [18F]FDG-PET CT for the evaluation of native valve endocarditis. J Nucl Cardiol 2020 Mar 16 [Epub]. https://doi.org/10.1007/s12350-020-02092-6.
  68. Ahmed FZ, James J, Tout D, Arumugam P, Mamas M, Zaidi AM. Metal artefact reduction algorithms prevent false positive results when assessing patients for cardiac implantable electronic device infection. J Nucl Cardiol 2015;22:219-20. https://doi.org/10.1007/s12350-014-9955-8
  69. Scholtens AM, Verberne HJ. Attenuation correction and metal artifact reduction in FDG PET/CT for prosthetic heart valve and cardiac implantable device endocarditis. J Nucl Cardiol 2018;25:2172-3. https://doi.org/10.1007/s12350-017-1176-5
  70. Scholtens AM, Swart LE, Kolste HJ, Budde RP, Lam MG, Verberne HJ. Standardized uptake values in FDG PET/CT for prosthetic heart valve endocarditis: a call for standardization. J Nucl Cardiol 2018;25:2084-91. https://doi.org/10.1007/s12350-017-0932-x
  71. Hyafil F, Rouzet F, Le Guludec D. Quantification of FDG uptake in patients with a suspicion of prosthetic valve endocarditis: part of the problem or part of the solution? J Nucl Cardiol 2018;25:2092-5. https://doi.org/10.1007/s12350-017-0999-4
  72. Rousset O, Rahmim A, Alavi A, Zaidi H. Partial volume correction strategies in PET. PET Clin 2007;2:235-49. https://doi.org/10.1016/j.cpet.2007.10.005
  73. Salavati A, Borofsky S, Boon-Keng TK, Houshmand S, Khiewvan B, Saboury B, et al. Application of partial volume effect correction and 4D PET in the quantification of FDG avid lung lesions. Mol Imaging Biol 2015;17:140-8. https://doi.org/10.1007/s11307-014-0776-6